Vanguard Group
MGLN

Vanguard Group’s Magellan Health Services, Inc. MGLN Stock Holding History

Vanguard Group’s Portfolio MGLN Stock Details MGLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,538,109
Closed -$241M – 4688
2021
Q4 		$241M Buy
2,538,109
+90,916
+4% +$8.61M 0.01% 1484
2021
Q3 		$231M Sell
2,447,193
-71,299
-3% -$6.74M 0.01% 1513
2021
Q2 		$237M Buy
2,518,492
+35,028
+1% +$3.3M 0.01% 1529
2021
Q1 		$232M Buy
2,483,464
+105,361
+4% +$9.87M 0.01% 1508
2020
Q4 		$197M Buy
2,378,103
+50,909
+2% +$4.03M 0.01% 1473
2020
Q3 		$176M Sell
2,327,194
-104,135
-4% -$7.73M 0.01% 1357
2020
Q2 		$177M Buy
2,431,329
+6,918
+0.3% +$443K 0.01% 1340
2020
Q1 		$117M Buy
2,424,411
+53,672
+2% +$3.45M 0.01% 1444
2019
Q4 		$186M Buy
2,370,739
+4,983
+0.2% +$350K 0.01% 1429
2019
Q3 		$147M Sell
2,365,756
-86,189
-4% -$5.74M 0.01% 1519
2019
Q2 		$182M Sell
2,451,945
-94,244
-4% -$6.34M 0.01% 1418
2019
Q1 		$168M Buy
2,546,189
+21,268
+0.8% +$1.36M 0.01% 1447
2018
Q4 		$144M Buy
2,524,921
+73,162
+3% +$4.51M 0.01% 1458
2018
Q3 		$177M Sell
2,451,759
-17,732
-0.7% -$1.43M 0.01% 1475
2018
Q2 		$237M Buy
2,469,491
+96,411
+4% +$9.24M 0.01% 1241
2018
Q1 		$254M Buy
2,373,080
+97,977
+4% +$9.84M 0.01% 1135
2017
Q4 		$220M Buy
2,275,103
+67,819
+3% +$6M 0.01% 1255
2017
Q3 		$190M Buy
2,207,284
+17,991
+0.8% +$1.42M 0.01% 1297
2017
Q2 		$160M Buy
2,189,293
+70,806
+3% +$4.97M 0.01% 1377
2017
Q1 		$146M Buy
2,118,487
+98,314
+5% +$7.18M 0.01% 1438
2016
Q4 		$152M Sell
2,020,173
-18,992
-0.9% -$1.22M 0.01% 1357
2016
Q3 		$110M Buy
2,039,165
+17,258
+0.9% +$1.04M 0.01% 1496
2016
Q2 		$133M Buy
2,021,907
+61,913
+3% +$4.17M 0.01% 1312
2016
Q1 		$133M Buy
1,959,994
+26,434
+1% +$1.59M 0.01% 1279
2015
Q4 		$119M Sell
1,933,560
-35,626
-2% -$1.91M 0.01% 1345
2015
Q3 		$109M Sell
1,969,186
-6,647
-0.3% -$402K 0.01% 1368
2015
Q2 		$138M Buy
1,975,833
+66,623
+3% +$4.53M 0.01% 1310
2015
Q1 		$135M Buy
1,909,210
+42,242
+2% +$2.66M 0.01% 1285
2014
Q4 		$112M Buy
1,866,968
+13,205
+0.7% +$780K 0.01% 1344
2014
Q3 		$101M Sell
1,853,763
-14,824
-0.8% -$851K 0.01% 1345
2014
Q2 		$116M Sell
1,868,587
-82,855
-4% -$4.87M 0.01% 1296
2014
Q1 		$116M Buy
1,951,442
+55,759
+3% +$3.32M 0.01% 1261
2013
Q4 		$114M Buy
1,895,683
+40,663
+2% +$2.43M 0.01% 1227
2013
Q3 		$111M Buy
1,855,020
+20,026
+1% +$1.16M 0.01% 1170
2013
Q2 		$103M Buy
+1,834,994
New +$96.1M 0.01% 1157

Vanguard Group's MGLN Position: Q1 2022 in Review

Vanguard Group sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 2,538,109 shares — an estimated $241M sold.

Vanguard Group first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $254M in Q1 2018. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

  • Vanguard Group reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
  • Vanguard Group sold 2,538,109 Magellan Health Services, Inc. shares in Q1 2022, an estimated $241M.
  • Vanguard Group first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
  • Vanguard Group's Magellan Health Services, Inc. position peaked at $254M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.

Based on Vanguard Group's 13F filing for Q1 2022, filed 13 May 2022.